Explore compound VIP$75.00
Skip to content
RESEARCH, REFINED.
The details
Considered compounds. Documented standards.Explore our standard
RESEARCH, REFINED.Recovery research
LL-37
5 mg / $75.00
LL-37 is a 37-residue cationic, amphipathic peptide — the only cathelicidin identified in humans.
Available formats
1
Availability and final pricing are checked at checkout.
1 laboratory report availableFor laboratory research use only. Not for human consumption.
A closer look
The details
behind the compound.
Overview
LL-37 is a 37-residue cationic, amphipathic peptide — the only cathelicidin identified in humans. It is released from the precursor hCAP18 by proteolytic cleavage and expressed by neutrophils, monocytes, mast cells, and epithelial cells; its skin expression is regulated by vitamin D.
It is a well-defined reference compound for recovery research, characterized for its host-defense and membrane-interacting behavior in laboratory models.
- CAS number
- 154947-66-7
Laboratory documentation
Check the product format and report identifiers before comparing results. Available reports do not establish the lot currently held in stock.
Vanguard LaboratoryAnalysis report · Lot L26C602View reportResearch references
Johansson J, et al. Conformation-dependent antibacterial activity of the human peptide LL-37. J Biol Chem. 1998.
Ridyard KE, Overhage J. The potential of human peptide LL-37 as an antimicrobial and anti-biofilm agent. Antibiotics. 2021.
Storage & handling
Store the lyophilized peptide at −20°C. Reconstituted solutions are best used promptly or frozen; the peptide is documented as notably stable in certain formulated matrices.
